Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-05-17
1991-03-19
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514171, 514177, 514178, 514182, A61K 31725, A61K 3156
Patent
active
050011162
ABSTRACT:
Angiogenesis in mammals is inhibited by administration of the active agents (1) heparin or a heparin fragment which is a hexasaccharide or larger or analogous compounds and (2) a steroid having 17.alpha.- and 21-hydroxy groups, 3- and 20-one groups, and in the 16-position hydrogen hydroxy or a methyl group, and non-toxic physiologically acceptable carboxylates, acetals, ketals and phosphates thereof.
REFERENCES:
patent: 3557158 (1971-01-01), Lincoln et al.
patent: 4771042 (1988-09-01), Beaughler et al.
Eichbaum, Anticoagulants and Cancer, A Review, Pesquisas Med. e Biol 8 (5-6):489-496 (1975).
Champion et al., Cancer 41(4), 1642-6 (1978).
Collins et al., Arch. Intern. Med., 138 (11), 1677-80 (1978).
Margileth, J. Pediatr. 92(6), 1030-31 (1978).
Edlis et al., Cancer Trtmt. Repts, 60(5), 575-8 (1976).
Elias et al., Cancer, 36(1), 129-36 (1975).
Israel et al., Tumori, 65, 99-104 (1979).
Kodama et al., Cancer Res.; 35, 1015-21 (1975).
Kostler, Dermatol. Monatsschrift, 162(6), 465-77 (1976).
Kotschy et al., Folia Haematol. (Leipzig) 107(1), 65-73 (1980).
Leavey et al., Cancer, 26(1), 142-5 (1970).
Drapkin et al., Cancer, 41(6), 2484-90 (1978).
Elias et al., Cancer Chemo. Repts, 56(6), 783-5 (1972).
Stevenson et al., Acta. Cytol. (Baltimore) 10(5), 383-6 (1966).
Yang et al., Proc. Soc. Expt'l Biol. Med., 159, 88-93 (1978).
Carnelli et al., J. Pediatrics, 91, 504-5 (1977).
Boneu-Valmalette et al., C.R. Soc. Biol. (Paris) 171(6), 1293-6 (1977).
Folkman et al., Science, 221, 719-25 (1983).
The Merck Index, 9th ed., Abstr. 4674, 7514, 7655, (1976).
Folkman Moses J.
Langer Robert S.
Taylor Stephanie
Henley III Raymond J.
Robinson Douglas W.
The Children's Medical Center Corporation
LandOfFree
Inhibition of angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of angiogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2010165